This is the authors' abstract. We don't add key points for this paper.
Nanopulse stimulation (NPS) presents a novel approach for cancer treatment. It applies high electric field pulses with ultrashort durations and fast rise-fall times, affecting the plasma membrane and intracellular structures and functions, inducing regulated cell death mechanisms that are immunogenic, eliminating tumors and their immunosuppressive tumor microenvironment, and activating innate and adaptive immune mechanisms. This results in tumor ablation and in situ vaccination against rat liver and mouse breast cancer. Here I provide a general overview of this technology and some finer points of the pulsed power technology.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Stephen J. Beebe (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: